CCB
AVNS

Cutter & Co Brokerage’s Avanos Medical AVNS Stock Holding History

Cutter & Co Brokerage’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-56,995
Closed -$2.63M – 249
2018
Q1 		$2.63M Sell
56,995
-7,088
-11% -$337K 1.04% 21
2017
Q4 		$2.96M Sell
64,083
-4,572
-7% -$210K 1.22% 18
2017
Q3 		$3.09M Sell
68,655
-4,225
-6% -$180K 1.23% 19
2017
Q2 		$2.86M Sell
72,880
-650
-0.9% -$24.6K 1.12% 20
2017
Q1 		$2.8M Sell
73,530
-750
-1% -$29.2K 1.16% 19
2016
Q4 		$2.75M Sell
74,280
-1,230
-2% -$44K 1.14% 22
2016
Q3 		$2.62M Sell
75,510
-3,120
-4% -$109K 1.14% 23
2016
Q2 		$2.56M Buy
78,630
+860
+1% +$26.3K 1.09% 26
2016
Q1 		$2.23M Sell
77,770
-1,755
-2% -$46.8K 1.03% 24
2015
Q4 		$2.66M Buy
79,525
+6,033
+8% +$188K 1.24% 21
2015
Q3 		$2.09M Buy
73,492
+6,750
+10% +$235K 1.03% 27
2015
Q2 		$2.7M Buy
66,742
+21,995
+49% +$987K 1.08% 26
2015
Q1 		$2.2M Buy
44,747
+52
+0.1% +$2.41K 0.9% 36
2014
Q4 		$2.03M Buy
+44,695
New +$1.76M 0.77% 41

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Cutter & Co Brokerage's AVNS Position: Q2 2018 in Review

Cutter & Co Brokerage sold out of Avanos Medical (AVNS) in Q2 2018, closing a stake of 56,995 shares — an estimated $2.63M sold.

Cutter & Co Brokerage first reported a position in AVNS in Q4 2014 and held it in 14 quarters. The position peaked at $3.09M in Q3 2017. 321 funds tracked by Wall St. Rank hold AVNS as of Q2 2018.

  • Cutter & Co Brokerage reported no remaining Avanos Medical position as of Q2 2018 after selling out during the quarter.
  • Cutter & Co Brokerage sold 56,995 Avanos Medical shares in Q2 2018, an estimated $2.63M.
  • Cutter & Co Brokerage first reported a position in Avanos Medical in Q4 2014 and held it in 14 quarters.
  • Cutter & Co Brokerage's Avanos Medical position peaked at $3.09M in Q3 2017.
  • 321 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2018.

Based on Cutter & Co Brokerage's 13F filing for Q2 2018, filed 30 Jul 2018.